Skip to main content
. Author manuscript; available in PMC: 2012 Oct 18.
Published in final edited form as: Drug Dev Res. 1996 Sep 1;39(1):36–46. doi: 10.1002/(sici)1098-2299(19960901)39:1<36::aid-ddr5>3.0.co;2-l

Figure 5.

Figure 5

Concentration-dependent effects of NECA (A), 2-CI-IBMECA (B), and the xanthine DBXRM (C) on intracellular calcium levels in RBL-2H3 mast cells. Cells were prelabeled with fura-2 as described in Methods. The adenosine analogs or xanthine (0.1, 0.3, 1, 3, 10 µM, from lower to upper trace) were added as indicated (arrows).